Misty Dawn Shields, Assistant Professor at Indiana University School of Medicine, shared a post on LinkedIn:
“As we wrap up 2025, there is an overwhelming gratefulness in my heart for the unprecedented advancements in treatments and research for SCLC!
Options that improved the care and lives of patients and their loved ones impacted by SCLC!
Thank you to ALL of the patients, families, advocates, researchers, investigators, trainees, nurses, pharmacists, healthcare personnel, philanthropy funding, pharmaceutical companies, and so many more… who sacrificed, invested, dreamed, and believed change COULD exist to ALTER the trajectory of this challenging disease.
These breakthroughs MATTER.
Each one helped gain one more moment, memory, hug, smile, day, month, year, or life back for our SMASHERS.
Thank you, 2025, for this much needed change. I am forever grateful.
Hopeful for what 2026 may bring.”
More posts featuring Misty Dawn Shields on OncoDaily.